Akebia Therapeutics reported $29.68M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Agios Pharmaceuticals AGIO:US USD 517K 82K
Akebia Therapeutics AKBA:US USD 29.68M 19.2M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amgen AMGN:US USD 1.75B 159M
Ardelyx ARDX:US USD 732K 594K
AstraZeneca AZN:LN USD 2.12B 214M
Bayer BAYN:GR EUR 4.25B 1.43B
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Exelixis EXEL:US USD 15.3M 1.82M
Fresenius Medical Care FME:GR EUR 3.74B 326.58M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
Johnson & Johnson JNJ:US USD 7.76B 29M
Karyopharm Therapeutics KPTI:US USD 980K 41K
Moderna Inc MRNA:US USD 1.1B 281M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Opko Health OPK:US USD 148.44M 45.87M
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Roche Holding ROG:VX 9.56B 717M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Vanda Pharmaceuticals VNDA:US USD 6.32M 261K